GlassScriptPhysician profile
Michael Kucharik
NPI 1235889676
$3,387.36
in general payments reported to CMS, 2019-2025
11 companies · $1,392 in 2025
The $1,392 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $24.10 · 2023: $385 · 2024: $1,586 · 2025: $1,392.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,363.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,363.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coastal Medical Technologies LLC | $1,172.54 | 2024-2025 | |
| Stryker Corporation | $931.42 | 2023-2025 | Citrefix, T2, Gamma |
| Zimmer Biomet Holdings, INC. | $281.01 | 2024-2025 | Comprehensive Shoulder System |
| Vericel Corporation | $244.76 | 2024-2025 | Maci |
| Linvatec Corporation | $243.93 | 2024-2025 | Biobrace 23mm |
| Polynovo North America LLC | $176.51 | 2025 | Novosorb Btm |
| Medical Device Business Services, INC. | $112.65 | 2025 | Vistaseal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.41 | 2024 | |
| Mvp Orthopedics INC | $56.52 | 2022-2023 | |
| Arthrex, INC. | $42.73 | 2025 | |
| Kci USA, INC. | $26.88 | 2023 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kucharik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.